ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,333Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 2588

$774K Total Retail Price of All Prescriptions

Rank: 175 out of 2588

360 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

21% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 13,584 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 687 634 1 5
HYDROCODONE-ACETAMINOPHEN 549 391 S3 2 7
LEVOTHYROXINE SODIUM 507 476 3 2
OMEPRAZOLE 461 401 4 6
AMLODIPINE BESYLATE 411 359 5 4
LISINOPRIL 406 359 6 3
PRAVASTATIN SODIUM 317 294 7 16
TRAMADOL HCL 297 245 8 19
ZOLPIDEM TARTRATE 283 238 9 24
WARFARIN SODIUM 278 257 10 10
GLIMEPIRIDE 264 235 11 39
RANITIDINE HCL 260 177 12 37
DIOVAN 244 231 13 29
HYDROCHLOROTHIAZIDE 235 213 14 13
METFORMIN HCL 231 189 15 8
ATORVASTATIN CALCIUM 219 206 16 11
LOSARTAN POTASSIUM 217 214 17 17
POTASSIUM CHLORIDE 215 204 18 15
DIGOXIN 203 195 19 38
CARVEDILOL 193 170 20 20
CITALOPRAM HBR 180 166 21 27
METOPROLOL TARTRATE 179 162 22 9
METOPROLOL SUCCINATE 175 166 23 12
ZETIA 170 149 24 69
PROAIR HFA 168 163 25 50
SPIRIVA 168 164 25 56
GABAPENTIN 161 150 27 18
KLOR-CON 10 155 151 28 75
FENOFIBRATE 137 105 29 64
ISOSORBIDE MONONITRATE ER 136 136 30 49
PREDNISONE 130 122 31 42
NAMENDA 129 118 32 32
CLONIDINE HCL 126 108 33 54
BYSTOLIC 125 118 34 110
TAMSULOSIN HCL 122 112 35 23
CRESTOR 120 81 36 25
ALLOPURINOL 115 115 37 33
DONEPEZIL HCL 113 113 38 22
SIMVASTATIN 111 109 39 1
SYNTHROID 106 96 40 88
FENTANYL 100 88 S2 41 78
RAMIPRIL 97 97 42 111
PANTOPRAZOLE SODIUM 97 96 42 28
CYMBALTA 96 58 44 70
NEXIUM 95 95 45 41
SINGULAIR 92 84 46 94
AVODART 89 77 47 164
KLOR-CON M20 89 76 47 52
ALENDRONATE SODIUM 83 83 49 21
CLOPIDOGREL 83 64 49 30
CYCLOBENZAPRINE HCL 82 58 R 51 87
JANUVIA 81 71 52 60
LOVASTATIN 80 69 53 34
SPIRONOLACTONE 79 62 54 58
DILTIAZEM HCL 74 72 55 228
METFORMIN HCL ER 72 72 56 67
LYRICA 66 41 57 100
TEKTURNA 65 65 58 283
FINASTERIDE 62 56 59 97
METHIMAZOLE 61 43 60 322
ADVAIR DISKUS 60 54 61 48
SOTALOL 58 58 62 297
DILTIAZEM 24HR ER 56 43 63 166
WELCHOL 55 55 64 343
DILTIAZEM ER 54 54 65 150
PRADAXA 53 50 66 207
MONTELUKAST SODIUM 53 49 66 153
VENLAFAXINE HCL ER 50 40 68 125
LOVAZA 50 44 68 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.